FDA Warning Letter — Purple Haze

Case 536955 — FEI 3013770679

The FDA took a Warning Letter action against Purple Haze on Sep 7, 2017 (Denver, CO). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Purple Haze
Date
Sep 7, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Denver, CO (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.